Aspirin resistance in hemodialysis patients

International Urology and Nephrology

Volumn 44, Issue 1, 2012, Pages 323-325

  Geara, Abdallah Sassine ^a   Azzi, Nassif ^b   Bassil, Claude ^b   El Sayegh, Suzanne ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; ASPIRIN RESISTANCE; CONTROLLED STUDY; DRUG RESISTANCE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LETTER; MAJOR CLINICAL STUDY; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR ACCESS; BLOOD; BLOOD CLOTTING PARAMETERS; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DRUG EFFECT; RENAL REPLACEMENT THERAPY;

ASPIRIN; DIABETES COMPLICATIONS; DRUG RESISTANCE; HUMANS; KIDNEY FAILURE, CHRONIC; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RENAL DIALYSIS; THROMBOSIS;

EID: 84861140034     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-010-9811-y     Document Type: Letter

References (15)

1. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR (2008) Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 336:195-198
2. Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S (2008) Assessing the current role of platelet function testing. Clin Cardiol 31:I10-I16
3. Chen WH, Lee PY, Ng W, Kwok JY, Cheng X, Lee SW, Tse HF, Lau CP (2005) Relation of aspirin resistance to coronary flow reserve in patients undergoing elective per-cutaneous coronary intervention. Am J Cardiol 96:760-763
4. Chen WH, Lee PY, Ng W, Tse HF, Lau CP (2004) Aspirin resistance is associated with a high incidence of myone-crosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43:1122-1126
5. Dyszkiewicz-Korpanty AM, Kim A, BurnerJD, Frenkel EP, Sarode R (2007) Comparison of a rapid platelet function assay-Verify Now Aspirin-with whole blood impedance aggregometry for the detection of aspirin resistance. Thromb Res 120:485-488
6. Polkinghorne K (2008) The CARI guidelines Pharmaco-logical approaches to preventing vascular access failure. Nephrology (Carlton) 13(Suppl 2):S12-S16
7. Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K (2010) Progression of aortic arch calcifi-cation and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol42:187-194
8. Acikel S, Yildirir A, Aydinalp A, Demirtas K, Bal U, Kaynar G, Ozin B, Karakayali H, Muderrisoglu H, Haberal M (2008) Incidence of aspirin resistance and its relation-ship with cardiovascular risk factors and graft function in renal transplant recipients. Transplant Proc 40:3485-3488
9. Hankey GJ, Eikelboom JW (2006) Aspirin resistance. Lancet 367:606-617
10. Gasparyan AY, Watson T, Lip GY (2008) The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 51:1829-1843
11. Bloom A, Greaves M, Preston FE, Brown CB (1986) Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis. Br J Haematol 62:143-149
12. Cavarape A, Bauer J, Bartoli E, Endlich K, Parekh N (2003) Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant 18:1764-1769
13. Spurney RF, Fan PY, Ruiz P, Sanfilippo F, Pisetsky DS, Coffman TM (1992) Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int 41:973-982
14. Lianos EA, Andres GA, Dunn MJ (1983) Glomerular pros-taglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest 72:1439-1448
15. Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R (2009) Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 30:426-435